• 12-O-tetradecanoyl phorbol-13-acetate (TPA): Precision Contr

  2026-05-19

  Explore how 12-O-tetradecanoyl phorbol-13-acetate (TPA) enables precise, tunable ERK/MAPK pathway activation for advanced disease modeling and signal transduction assay design. This article delivers a deeper mechanistic perspective, focusing on actionable insights for researchers.

• Distinct Apoptotic Pathways in BMECs Induced by C. krusei Ph

  2026-05-18

  This study demonstrates that Candida krusei induces apoptosis in bovine mammary epithelial cells (BMECs) via distinct mechanisms, with the yeast phase activating a mitochondrial pathway and the hypha phase triggering a death ligand/receptor pathway. The findings deepen our understanding of mycotic mastitis pathogenesis and point to specific MAPK signaling components as potential therapeutic targets.

• Universal Method for Dual-Loaded Liposome Encapsulation Effi

  2026-05-18

  This study introduces a robust nanoparticle exclusion chromatography (nPEC) method for accurately determining the encapsulation efficiency of dual-loaded liposomes containing both hydrophilic and lipophilic drugs. The findings advance drug delivery research by enabling precise, reproducible assessment across diverse compound pairs, supporting translational applications in combination therapy.

• PPM-18 for Precision NF-κB Inhibition in Sepsis Research

  2026-05-17

  PPM-18, a potent NF-κB pathway inhibitor, empowers researchers to achieve reproducible iNOS modulation in inflammation and sepsis models. Applied insights, protocol guidance, and troubleshooting tips maximize its impact for translational studies.

• Cannabidiol’s Role in Modulating Orofacial Inflammatory Pain

  2026-05-16

  This study demonstrates that cannabidiol (CBD) robustly attenuates both sensory and affective dimensions of orofacial inflammatory pain in mouse models, acting through peripheral and central endocannabinoid and serotonergic pathways. These findings highlight CBD’s translational potential for integrated management of pain and mood disturbances, and inform future investigations into endocannabinoid signaling modulation.

• Glabridin-Gold(I) Complex Enhances Antitumor Immunity via Tr

  2026-05-15

  This study introduces a glabridin-gold(I) complex (6d) as a novel immunomodulatory agent that synergistically targets thioredoxin reductase and MAPK pathways, enhancing antitumor immunity in liver cancer models. The dual-action mechanism not only boosts dendritic cell maturation and cytotoxic T cell activity but also reduces immunosuppressive cell populations, offering a promising strategy for combinatorial cancer immunotherapy.

• Protease Inhibitor Cocktail: Precision Protein Extraction Un

  2026-05-15

  Unlock uncompromised protein stability for Western blotting, Co-IP, and phosphorylation-sensitive assays with APExBIO’s EDTA-free Protease Inhibitor Cocktail. Its DMSO-based, 200X concentrated format enables broad-spectrum, cation-friendly protection, empowering reproducible results in both discovery and translational workflows.

• Anti-Fibrotic Actions of 1-Phenyl-2-Pentanol in Hepatic Stel

  2026-05-14

  This study identifies 1-phenyl-2-pentanol from Moringa oleifera as a potent regulator of hepatic stellate cell activation, targeting both TGF-β1 and Wnt/β-catenin pathways to suppress fibrogenic signaling. The findings highlight a dual-mechanism approach for anti-fibrotic intervention, providing new directions for liver fibrosis research.

• Difloxacin HCl: Optimizing Antimicrobial and MDR Assays

  2026-05-14

  Difloxacin HCl stands out as a high-purity quinolone antimicrobial antibiotic, enabling precise antimicrobial susceptibility testing and robust reversal of multidrug resistance in research settings. This article delivers actionable protocol enhancements, troubleshooting strategies, and cross-domain workflow insights for biomedical researchers seeking reproducible and efficient outcomes.

• Polyethylenimine Linear (PEI), MW 40,000: Reliable DNA Trans

  2026-05-13

  This article delivers a scenario-driven, evidence-based exploration of Polyethylenimine Linear (PEI), MW 40,000 (SKU K1029) for in vitro DNA transfection, transient gene expression, and recombinant protein production. Drawing on real laboratory challenges, protocol optimizations, and peer-reviewed literature, it demonstrates how SKU K1029 enables reproducible, high-efficiency transfection across diverse cell lines and scales.

• Polyethylenimine Linear (PEI MW 40,000): High-Efficiency DNA

  2026-05-13

  Polyethylenimine Linear (PEI MW 40,000) is a robust DNA transfection reagent for in vitro studies, delivering high efficiency across mammalian cell lines from 96-well plates to bioreactors. Its versatility, serum compatibility, and performance in transient gene expression and recombinant protein production set it apart for both routine and large-scale applications.

• Asymmetric Synthesis of Axially Chiral Antimitotic Biaryls

  2026-05-12

  This study pioneers an atropo-enantioselective Suzuki cross-coupling approach for synthesizing axially chiral biaryls with potent antimitotic activity, exemplified by analogues of (-)-rhazinilam. The work provides a robust synthetic route for generating bioactive, structurally complex molecules relevant to microtubule-targeted research and sets a benchmark for enantioselective biaryl synthesis.

• Entecavir (BMS200475): Optimizing HBV Replication Inhibition

  2026-05-12

  Entecavir (BMS200475) enables reliable, selective inhibition of chronic hepatitis B virus replication in both wild-type and lamivudine-resistant models. This guide details robust experimental workflows, troubleshooting insights, and comparative advantages for researchers and clinicians leveraging Entecavir from APExBIO.

• Applied Workflows with Angiotensin III: RAAS, Assay Design,

  2026-05-11

  Angiotensin III (Arg-Val-Tyr-Ile-His-Pro-Phe) is redefining experimental precision in cardiovascular and neuroendocrine research as a potent aldosterone secretion inducer and pressor activity mediator. This article delivers protocol-driven insights, troubleshooting guidance, and a translational bridge to viral pathogenesis, all anchored by the latest peer-reviewed evidence and APExBIO’s validated reagent.

• Antimycin A4: Applied Workflows for ATP-Citrate Lyase Inhibi

  2026-05-11

  Antimycin A4 is a dual-action ATP-citrate lyase inhibitor and mitochondrial respiratory chain blocker, uniquely enabling high-fidelity interrogation of lipid, cholesterol, and energy metabolism. This guide distills validated workflows, troubleshooting insights, and recent advances to help researchers maximize reproducibility and data quality using APExBIO's Antimycin A4.

16635 records 8/1109 page Previous Next First page 上5页 678910 下5页 Last page